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Mammalian genomes are organized into megabase-
scale topologically associated domains (TADs). We
demonstrate that disruption of TADs can rewire
long-range regulatory architecture and result in path-
ogenic phenotypes. We show that distinct human
limb malformations are caused by deletions, inver-
sions, or duplications altering the structure of the
TAD-spanningWNT6/IHH/EPHA4/PAX3 locus. Using
CRISPR/Cas genome editing, we generated mice
with corresponding rearrangements. Both in mouse
limb tissue and patient-derived fibroblasts, dis-
ease-relevant structural changes cause ectopic in-
teractions between promoters and non-coding
DNA, and a cluster of limb enhancers normally asso-
ciated with Epha4 is misplaced relative to TAD
boundaries and drives ectopic limb expression of
another gene in the locus. This rewiring occurred
only if the variant disrupted a CTCF-associated
boundary domain. Our results demonstrate the func-
tional importance of TADs for orchestrating gene
expression via genome architecture and indicate
criteria for predicting the pathogenicity of human
structural variants, particularly in non-coding regions
of the human genome.1012 Cell 161, 1012–1025, May 21, 2015 ª2015 Elsevier Inc.INTRODUCTION
Approximately 5% of the human genome is structurally variable
in the normal population, which includes deletions and duplica-
tions (collectively referred to as copy number variants, CNVs),
as well as inversions, and translocations. Structural variations
have received considerable attention as a major cause for ge-
netic disease, promoting the search for CNVs as a standard
diagnostic procedure in conditions such as intellectual disability
and congenital malformations (Stankiewicz and Lupski, 2010;
Swaminathan et al., 2012). The pathogenicity of many CNVs
can be explained by their effect on gene dosage. In contrast, it
is difficult to predict the consequences of balanced rearrange-
ments, such as inversions, or the functional impact of CNVs
that are limited to non-coding DNA. Such variants have the po-
tential to disrupt the integrity of the genome, causing changes
in the regulatory architecture that lead to pathogenic alterations
of gene expression levels and patterns (Haraksingh and Snyder,
2013; Spielmann and Mundlos, 2013). However, the lack of a
comprehensive understanding of the large-scale functional or-
ganization of the regulatory genome is a major limitation in pre-
dicting their potential pathogenicity.
New methods for enhancer identification and analysis of
chromosome conformation have enabled substantial progress
toward elucidating genome-wide regulatory interactions. Chro-
matin immunoprecipitation sequencing (ChIP-seq) performed
directly on ex vivo tissues can reveal the location of distant-
acting tissue-specific enhancer sequences at genomic scale
(Visel et al., 2009a). In parallel, sequencing-based studies of
DNA-DNA interactions have provided insight into the general
conformation of the genome in living cells, as well as interactions
between promoters and distant-acting transcriptional enhancers
in specific cell types (Lieberman-Aiden et al., 2009). These data
also show that enhancers can control multiple genes, frequently
over hundreds of kilobases away from their target. Only a fraction
of enhancers contact the nearest promoter, whereas most skip
one or more genes (de Laat and Duboule, 2013). How the selec-
tive interaction of enhancers with their respective target genes
is achieved remains largely unknown, but the organization of
the genome in domains of interaction that are shielded from
each other by boundaries appears to be critical. Genome-wide
interaction studies by chromosome conformation capture-
based approaches such as Hi-C (a high-throughput variant of
the chromosome conformation capture technique [3C]) and 5C
(chromosome conformation capture carbon copy) show that
the genome is partitioned into megabase-scale topologically
associated domains (TADs) (Dixon et al., 2012; Nora et al.,
2012). These domains have been proposed to represent regula-
tory units within which enhancers and promoters can interact.
They are separated by boundary regions that often contain
CTCF binding sites or housekeeping genes representing de
facto insulators that block interactions across adjacent TADs
(Dixon et al., 2012). The importance of TAD structures is further
supported by the finding that TAD boundaries appear to be
largely static across different species and cell types. This sug-
gests the existence of a preformed and stable topology that or-
ganizes the physical proximity between enhancers and their
target genes. However, the observation that TADs exist regard-
less of transcriptional status has also raised questions regarding
their role in cell- and tissue-specific regulatory processes (de
Laat and Duboule, 2013). Furthermore, it has remained unclear
if alterations in TAD structure, as they may occur in genomic re-
arrangements, can contribute to disease etiology.
In the present study, we analyze the potential value of anno-
tated TAD boundaries for understanding how structural variation
in the human genome elicits pathogenic phenotypes. Focusing
on families with rare limbmalformations, we identified several re-
arrangements in the extended WNT6/IHH/EPHA4/PAX3 region
and re-engineered them in mice. Through a series of circular
chromosome conformation capture sequencing (4C-seq) exper-
iments and expression studies in mouse limb tissue and human
patient-derived cells, we show that the rearrangements disrupt
the normal topology of protein-coding genes and their en-
hancers relative to TAD boundaries, resulting in inappropriate in-
teractions and misexpression. Our results highlight the utility of
considering the three-dimensional architecture of the genome
for predicting the consequences of structural variation and rein-
force that this approach may be useful for the analysis of struc-
tural variants in a wide spectrum of human disease phenotypes.
RESULTS
Disruptions of TAD Structure at the EPHA4 Locus Are
Associated with Limb Phenotypes
The EPHA4 gene resides within a large gene desert flanked by a
gene-dense region on the centromeric side and the PAX3 geneon the telomeric side. Hi-C data show that the region is orga-
nized into three adjacent TADs, the largest encompassing
EPHA4 (Figure 1A) (Dixon et al., 2012). Studying the genetic
causes of rare limbmalformations, we identified a series of struc-
tural variants at the EPHA4 locus that potentially interfere with
the integrity of this region. In mice, Epha4 is expressed during
limb development and required for normal innervation of the
limb, but inactivation of Epha4 does not cause changes in the
limb skeleton (Helmbacher et al., 2000).
First, we investigated a dominantly inherited novel type of
brachydactyly in three unrelated families, characterized by short
digits predominantly on the preaxial (radial) side resulting in stub
thumbs, short index fingers and a cutaneous web between the
first and second fingers (Figure 1B; Figure S1). High-resolution
array comparative genome hybridization (CGH) revealed hetero-
zygous deletions of 1.75–1.9 Mb on chromosome 2q35-36 in all
three affected families. All three deletions include the EPHA4
gene along with a large portion of its surrounding TAD and
extend into the non-coding part of the adjacent PAX3 TAD,
thereby removing the predicted boundary between the EPHA4
and PAX3 TADs.
Second, we studied the molecular cause of F-syndrome, a
limb malformation syndrome characterized by severe and com-
plex syndactyly, often involving the first and second fingers, and
polydactyly of the feet (Figure 1C) (Grosse et al., 1969). F-syn-
drome had previously been mapped to this chromosomal region
(2q36), but its genetic cause remained unknown (Camera et al.,
1995; Thiele et al., 2004). We used whole-exome sequencing
to detect mutations in genes located in the linkage interval but
were not able to identify any potentially pathogenic changes.
To search for non-coding mutations and structural variations,
we used whole-genome sequencing. We detected a 1.1-Mb
heterozygous inversion in family F1 and a 1.4-Mb heterozy-
gous duplication, arranged in direct tandem orientation, in family
F2. The telomeric breakpoints were located 1.4 Mb away from
the EPHA4 gene within the gene desert in the case of the inver-
sion and 1.2 Mb in the case of the duplication. The centromeric
breakpoints were located centromeric and telomeric ofWNT6 in
the duplication and inversion, respectively (Figure 1C). Of note,
both rearrangements bring the centromeric portion of the
EPHA4-containing TAD into close proximity of the WNT6 gene.
Third, we studied a family that carries a heterozygous
900-kb duplication in chromosomal region 2q35 that results
in severe polysyndactyly and craniofacial abnormalities (Fig-
ure 1D) (Yuksel-Apak et al., 2012). The phenotype is reminiscent
of the doublefoot (Dbf) mouse mutant, which also features
massive polysyndactyly and was shown to be caused by a
600-kb deletion affecting the same region (Babbs et al.,
2008). Of note, both the human and the mouse alleles bring the
IHH/Ihh gene in proximity to the centromeric portion of the
EPHA4-containing TAD.
Chromatin Interaction Landscape of the Extended
WNT6/IHH/EPHA4/PAX3 Region
To elucidate the genetic basis of these birth defects, we sought
to examine the regulatory landscape at this locus in more detail.
In addition to EPHA4, we focused on the IHH,WNT6, and PAX3
genes due to their location near breakpoints in patients and theirCell 161, 1012–1025, May 21, 2015 ª2015 Elsevier Inc. 1013
Figure 1. Different Limb Pathogenic Structural Variations in Human and Mouse Map to the EPHA4 TAD
(A) Hi-C profile around the EPHA4 locus in human ESCs (Dixon et al., 2012). Dashed lines indicate the EPHA4 TAD and boundaries. Cen, centromeric; tel,
telomeric.
(B–D) Schematic of structural variants (left) and associated phenotypes (right). (B) Brachydactyly-associated deletions in families B1, B2, and B3. Note thumb and
index finger shorteningwith partial webbing in a child (B1 patient) and adult (B2 patient). (C) F-syndrome-associated inversion in family F1 and duplication in family
F2. Note similar phenotypes of index/thumb syndactyly. (D) Polydactyly-associated duplication (P1) and deletion in the doublefoot (Dbf) mouse mutant. The
radiograph of the patient’s hand and the skeletal preparation of the Dbf/+ mouse show similar seven-digit polydactyly.
See also Figure S1.involvement in other developmental processes (Geetha-Logana-
than et al., 2010; Goulding et al., 1994; St-Jacques et al., 1999).
In each of the human disease alleles, at least one of the predicted
TAD boundaries would be disrupted or its position changed rela-
tive to the four genes highlighted above (Figure 1). As illustrated
in Figures 1 and 2, Hi-C data from human and mouse cells show
a very similar TAD structure (Dixon et al., 2012), indicating that
mice could serve as a model system for these diseases. To
test if the TAD structure observed in embryonic stem cells
(ESCs) by Hi-C is consistent with the chromatin conformation
in the developing limb, we performed 4C-seq experiments in
E11.5 mouse limb buds using the promoters of Epha4, as well
as Ihh,Wnt6, and Pax3 as baits. For each promoter we observed
interaction domains that were compatible with the Hi-C pre-1014 Cell 161, 1012–1025, May 21, 2015 ª2015 Elsevier Inc.dicted TADs (Figure 2). These results confirm that the general
TAD organization identified by Hi-C around the Epha4 locus is
consistent with the interaction landscape during limb develop-
ment obtained with 4C-seq.
CRISPR-Mediated Re-engineering of Human Disease
Alleles in Mice
To study the effects of the structural variants observed in human
patients in an experimentally accessible in vivo system, we
generated mice with genome rearrangements recapitulating
the human disease alleles. Using a protocol adapted for the
introduction of large structural variants (Kraft et al., 2015), we co-
transfected pairs of single guide RNAs (sgRNAs) into mouse
ESCs to induce double strand breaks at desired positions.
Figure 2. TAD Organization around the Wnt6/Ihh/Epha4/Pax3 Locus
Hi-C profile derived from mouse ESCs (Dixon et al., 2012). Predicted TAD boundaries are indicated by vertical dashed lines. 4C-seq profiles from E11.5 mouse
distal limbs with viewpoints onWnt6, Ihh, Epha4, and Pax3 are shown. The y axis indicates number of normalized reads. 4C-seq interactions sharply drop at the
Hi-C-predicted boundaries. The percentage of contacts per megabase within the TADs is shown on right. Orange bars represent contacts within corresponding
TAD. Grey bars represent contacts located in the respective next two centromeric TADs and two telomeric TADs.To generate a mouse model for the human brachydactyly
cases, mouse line DelB was created from ESC clones carrying
a corresponding CRISPR-induced deletion (Figures 3A and
3B). Heterozygous DelB/+ mice showed shortening of the sec-
ond and third digits due to hypoplastic phalanges, which was
most pronounced in the middle phalanx of the second digit (Fig-
ure S2). This phenotype increased in severity when mice were
bred to homozygosity, leading to severe shortening of the sec-
ond digits due to very short middle phalanges, syndactyly be-
tween the second and third digits, and a deviation of these digits
toward the radial side (Figure 3E, DelB/DelB). The phenotype is
very similar to the humanmalformation that is also characterized
by short thumb and index finger due to short or missing middle
phalanges and partial syndactyly (Figure 1B). Thus, mutant
mice with a deletion corresponding to the human disease alleles
recapitulated the phenotype observed in patients. In addition to
these digit malformations, homozygous DelB/DelB mice alsoshowed the known phenotype resulting from Epha4 inactivation,
i.e., a resultant hopping gait due to gross motor dysfunction
(Helmbacher et al., 2000).
To create amousemodel of structural variants found in human
F-syndrome patients, we reproduced the inversion observed in
family F1 in mice. We obtained heterozygous and homozygous
ESC clones carrying a 1.06-Mb CRISPR-induced inversion
with breakpoints at comparable positions in the mouse locus
(Figure 3C). Heterozygous as well as homozygous newborns
generated via tetraploid aggregation died shortly after birth of
unknown cause and did not show overt limb phenotypes or other
morphological defects (data not shown).
Finally, we re-examined the previously described doublefoot
(Dbf) mutant mouse strain due to the parallels in phenotype
and genomic rearrangement with the human polydactyly pa-
tients (Figure 3D) (Yuksel-Apak et al., 2012). Dbf/+ mice have
six to nine digits per limb in a mirror image position with loss ofCell 161, 1012–1025, May 21, 2015 ª2015 Elsevier Inc. 1015
Figure 3. Ectopic Interaction ofWnt6, Ihh, and Pax3 with the Epha4 TAD and Misexpression in Mouse Models
(A) Schematic of the locus. Dashed lines indicate Epha4 TAD and boundaries. In situ hybridization (right) shows Epha4 expression in distal limbs of an E11.5 wild-
type embryo (white arrow).
(B) Brachydactyly-like deletion generated by CRISPR/Cas (pink scissors). 4C-seq analysis with Pax3 as a viewpoint in E11.5 wild-type and heterozygous mutant
distal limbs shows ectopic interaction with the centromeric part of the Epha4 TAD in the mutant (red box). Pax3 shows ectopic distal limb expression in mutants
(white arrow).
(C) F-syndrome inversion generated by CRISPR/Cas (pink scissors). 4C-seq analysis with Wnt6 as a viewpoint shows ectopic interaction with the centromeric
part of the Epha4 TAD in the mutant (red box). Wnt6 shows ectopic distal limb expression in mutant limbs (white arrow).
(D)Dbf deletion. 4C-seq analysis with Ihh as a viewpoint shows ectopic interaction with most of the Epha4 TAD inmutants (red box). Ihh shows ectopic distal limb
expression in mutants (white arrow).
(E and F) Autopod and corresponding skeletal preparations of wild-type and mutant mice at postnatal day 3. Insets in (E) show digit II. Note reduction of digit II in
the homozygous brachydactyly-like deletion and massive polydactyly in Dbf/+.
See also Figures S2, S3, and S4.
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anterior-posterior differences and no thumb-equivalent bipha-
langeal digit I (Figure 3F). Patients with polydactyly resulting
from duplication P1 have a very similar limb phenotype consist-
ing of severe polydactyly, complete fusion of digits (syndactyly),
and amirror configuration of the digits (Figure 1D). In two of three
cases the mouse phenotypes closely resemble the human
congenital limb defects, further supporting the utility of these
mouse models.
Structural Changes Cause Misexpression of
Developmental Genes Resembling the Endogenous
Epha4 Pattern
The general nature of the structural variations and the resem-
blance of phenotypes resulting from inversion and duplication
(F-syndrome) or duplication and deletion (polydactyly/Dbf)
raise the possibility that these phenotypes are caused by
convergent alterations in gene regulation. In the case of Dbf
mice, ectopic expression of Ihh in the embryonic limb was previ-
ously described (Babbs et al., 2008). To examine the new
CRISPR-engineered lines for aberrant expression, we per-
formed RNA-seq experiments in E11.5 limbs of wild-type,
DelB/+ (brachydactyly-like deletion), InvF/InvF (F-syndrome-
like inversion), and Dbf/+ (polydactyly) embryos. We analyzed
the chromosomal region around theWnt6/Ihh/Epha4/Pax3 locus
(chromosome 1: 73000000–79000000, mm9), for altered levels
of gene expression related to the corresponding structural vari-
ation. We detected a significant upregulation of Pax3 in DelB/+
limbs, of Wnt6 in InvF/InvF limbs, and of Ihh in the Dbf/+ limbs,
whereas all other surrounding genes were unaltered or showed
only marginal increases in expression levels (Figure S3). As ex-
pected, Epha4, which is contained in the brachydactyly (DelB)
deletion, and all the genes located within the Dbf deletion were
downregulated. On the basis of these results, we analyzed the
expression patterns of Pax3, Wnt6, and Ihh in the respective
mouse mutants by in situ hybridization at E11.5 and compared
them with the wild-type Epha4 expression pattern.
Epha4 is expressed in a distinct pattern in the developing limb,
mainly in the distal mesoderm with predominance to the anterior
side (Figure 3A, right). At the same developmental stage, Pax3 is
also expressed in the limb bud, but restricted to migrating mus-
cle cells, evident as faint staining in the proximal limb, and absent
from the developing hand plate (Figure 3B, top right). DelB/+
(brachydactyly-like deletion) mice showed strong misexpression
of Pax3 in the distal anterior part of the autopod, in a pattern
resembling endogenous Epha4 expression (Figure 3B, bottom
right). Wnt6 is normally expressed in the limb bud ectoderm,
but not the distal mesoderm where Epha4 is expressed (Fig-
ure 3C, top right). In InvF/InvF (F-syndrome-like inversion)
mice, we observed strong misexpression of Wnt6 in the distal
limb autopod mesenchyme, in a similar pattern to Epha4 in
wild-type controls and Pax3 in DelB/+ mice (Figure 3C, bottom
right). The same pattern of misexpression was observed for het-
erozygous InvF/+mice (not shown). Finally, Ihh is not expressed
at all in the limb bud autopod at E11.5 (Figure 3D, top right). Mis-
expression of Ihh in the distal limb bud of Dbf mutants was pre-
viously demonstrated (Babbs et al., 2008), and comparison at
E11.5 revealed a striking resemblance of the expression pattern
with Epha4 in wild-type embryos (Figure 3D, bottom right). Takentogether, these results indicate that genes near the chromo-
somal breakpoints are misexpressed in all three mouse lines.
In all cases, the acquired expression domain closely resembles
the endogenous expression pattern of Epha4, suggesting that
regulatory sequences normally controlling Epha4 may play a
role in the pathogenesis of the human limb phenotypes.
4C-Seq Reveals Ectopic Interaction of Misexpressed
Genes with the Epha4 TAD
Toexaminewhether the structural variants result in aberrant chro-
matin interactions that may explain the ectopic expression do-
mains observed in mutant mice, we performed 4C-seq on distal
E11.5 limbs. We analyzed the different mutants and stage-
matched wild-type embryos, using the promoters of Pax3,
Wnt6, and Ihh as baits (Figures 3B–3D). For the deletions (DelB
and Dbf), heterozygous animals were examined in order to mini-
mize the possibility of deleterious effects that otherwise may
result from homozygous deletion of genes. For the copy num-
ber-balanced inversion (InvF), weexaminedhomozygous animals
because no genes are deleted and the absence of the wild-type
allele simplifies the interpretation of the 4C-seq data. In wild-
type distal limbs, 4C-seq experiments showed minimal interac-
tion of Pax3, Wnt6, and Ihh with non-coding sequences in the
Epha4 TAD. In contrast, all three genes showed substantial inter-
action with the Epha4 TAD in the mutants. In the DelB/+ (brachy-
dactyly-like deletion) mice, Pax3 showed a novel interaction
domain of 800 kb, spanning the remaining part of the Epha4
TAD flanking the centromeric breakpoint (Figure 3B). In InvF/
InvF (F-syndrome-like inversion), we detected strong interaction
of Wnt6 with a 300-kb region that corresponds to the centro-
meric part of the Epha4 TAD, brought to the vicinity of Wnt6
through the inversion (Figure 3C). For better visualization, we
mapped the 4C-seq data to a reference sequence that includes
the inversion as present in the mice (Figure S4). Comparison
with 4C-seq data from wild-type embryos showed that the inter-
action levels substantially exceed interactions with equidistant
sequences in wild-type limb buds. Finally, the Dbf/+ deletion
showed extensive interactions of Ihh with sequences throughout
the entire Epha4 TAD (Figure 3D). Thus, all rearrangements re-
sulted in novel interactions within the Epha4 TAD and a fusion of
adjacent TADs. Remarkably, all novel interactions in the fused
TADs respected the adjacent boundaries, i.e., Ihh and Wnt6 did
not show interaction with the Pax3 domain and vice versa.
Disrupted TADs Result in Ectopic Interaction in Patient
Cells
Previous studies showed that TADs are highly stable across spe-
cies and cell lines (Dixon et al., 2012), raising the possibility that
patient-derived samples can provide direct insight into regulato-
ry aberrations that affect early embryonic development. To test
this paradigm, we applied 4C-seq to human adult fibroblasts
(HAFs) and compared the results to data from the mutant mouse
strains. We processed HAFs from a brachydactyly patient of
family B1, a patient with F-syndrome from family F2 (cells from
F1 were not available), and a polydactyly patient (P1) with
the duplication. We compared patient samples with HAFs
from age-, sex-, and passage-matched healthy control donors
(Figure 4). All controls showed a 4C-seq profile that was highlyCell 161, 1012–1025, May 21, 2015 ª2015 Elsevier Inc. 1017
Figure 4. 4C-Seq Analysis in Patient-Derived Human Adult Fibroblasts
(A–C) Schematic representation of the locus and the structural variations are shown on top. 4C-seq profiles from human adult fibroblasts from healthy controls
and patients with heterozygous structural variations are shown below. Red boxes indicate ectopic interaction. The EPHA4 TAD is indicated by dashed lines.
(A) Patient with brachydactyly-associated deletion. 4C-seq analysis with PAX3 as a viewpoint shows extensive ectopic interaction with the EPHA4 TAD (red box).
(B) Patient with the F-syndrome-associated duplication. The 4C-seq profile withWNT6 as a viewpoint shows ectopic interaction with the EPHA4 TAD (red box).
(C) Patient with the polydactyly-associated duplication. The 4C-seq profile with IHH as a viewpoint shows ectopic interaction with the centromeric region of the
EPHA4 TAD (red box).similar to that observed in mouse limbs (Figure 2) and human
Hi-C data (Figure 1, top). Similar to DelB mice, the human
brachydactyly-associated deletion resulted in aberrant contact
of the PAX3 promoter region with the centromeric part of the
EPHA4 TAD (Figure 4A). Likewise, the F-syndrome-associated
duplication showed an ectopic interaction domain in the cen-
tromeric regions of the EPHA4 TAD, closely resembling the
interaction domain gained in InvF mice (Figure 4B). Finally, the1018 Cell 161, 1012–1025, May 21, 2015 ª2015 Elsevier Inc.polydactyly-associated human duplication resulted in an over-
lapping, smaller interaction domain in the most centromeric re-
gion of the EPHA4 TAD (Figure 4C). While individual reads could
not be unambiguously traced to one of the two copies present in
the duplication allele, one plausible explanation for this observa-
tion are ectopic interactions between the telomeric copies of
Wnt6/Ihh and the centromeric copy of the duplicated regions
of the EPHA4 TAD.
Figure 5. A Cluster of Limb Enhancers Is Located in the Interacting Region of the EphA4 TAD
(A) Color bars indicate the fragment of the Epha4 TAD showing increased interaction with target genes in different mouse mutant limbs or human patient
fibroblasts. The 4C-seq profile of Epha4 in E11.5 distal mouse limbs is shown for comparison. The red box indicates region of minimal overlap analyzed for
enhancer activity.
(B) Close-up view of the chromosomal region analyzed. DNase HS, H3K27ac, and p300 ChIP-seq from E11.5 limbs and conservation tracks were used to predict
enhancers. Arrows indicate putative enhancer regions. The gray box indicates the location of a cluster of enhancers shown below (C).
(C) Transgenic enhancer reporter (LacZ) staining at E11.5.
(D) Pattern of forelimb expression of Pax3 (DelB), Wnt6 (InvF), and Ihh (Dbf) in mutants and endogenous pattern of expression of Epha4 by in situ hybridization
at E11.5. Note the similarity of endogenous Epha4 and ectopic Pax3, Wnt6, and Ihh expression domains (D, white arrows) with the enhancer activity patterns
(C, black arrows).
See also Figures S5 and S6.DeNovo Interaction betweenDistal LimbEnhancers and
Ectopic Target Genes upon TAD Reorganization
Comparisons between the 4C-seq profiles obtained from the
different mutant mouse tissues and patient cells revealed aminimal common region of 150 kb within the EPHA4 TAD
(Figure 5A). 4C-seq analysis of distal wild-type mouse limbs
at E11.5 showed that this region frequently interacts with the
EPHA4 promoter during normal development across 1.66 MbCell 161, 1012–1025, May 21, 2015 ª2015 Elsevier Inc. 1019
of the intervening gene desert (Figure 5A). To identify en-
hancers with regulatory activity during limb development, we
screened public ChIP-seq data for enhancer-associated chro-
matin marks, DNase hypersensitive sites (HS) data from equiv-
alent developmental stages (E11.5) for open chromatin, and
sequence conservation in this region (Figure 5B). To examine
the strongest candidate sequences identified through this
screen in more detail, we studied the in vivo activity pattern
of five candidate enhancers. Two of these regions were already
studied and documented in the VISTA enhancer browser data-
base (Visel et al., 2007). The remaining three were tested for
enhancer activity using a transgenic mouse LacZ enhancer re-
porter system.
At E11.5, four of the five regions showed reproducible LacZ re-
porter activity in the developing limb. Three of these enhancers,
clustered in a 30-kb region, showed a high degree of spatial
overlap with the endogenous expression pattern of Epha4, as
well as the ectopic expression domains of Pax3, Ihh, and Wnt6
gained in DelB, Dbf, and InvF mice, respectively (Figures 5C
and 5D; Figure S5).
To confirm that the interactions in this region previously
observed in mouse wild-type and mutant limbs involve these en-
hancers, we performed 4C-seq using the enhancer cluster as
bait. The interaction profile revealed that this region interacts
frequently with Epha4 during development in wild-type distal
limbs (Figure S6, top). Next we tested if these enhancers had
contact with the promoters of Pax3, Wnt6, or Ihh in the distal
limbs of mutants compared with wild-type controls (Figure S6,
bottom). This analysis confirmed that in all three cases, as a
consequence of the different structural variations, new interac-
tions are established between limb enhancers located inside
the Epha4 TAD and genes outside the domain.
Boundaries of the EPHA4 TAD Determine the
Pathogenicity of Structural Variants
All structural variants examined do not only change the arrange-
ment of genes, enhancers, and predicted TAD boundaries
relative to each other but also result in changes in the distance
between enhancers and their possible target genes. To investi-
gate if the observed ectopic interactions are caused by disrup-
tion of boundary elements or merely by distance effects, we
examined the role of the putative boundaries at either side of
the Epha4 TAD in additional mouse mutants. Regions with
boundary-like properties were suggested by the Hi-C data
(Dixon et al., 2012). The analysis of CTCF ChIP-seq data in hu-
man and mouse cell lines and tissues (ENCODE Project Con-
sortium, 2004) showed an absence of CTCF binding sites within
the Epha4 TAD and the presence of several CTCF peaks at each
boundary region (Figure 6A). To investigate the possible role of
the border regions flanking the Epha4 TAD, we generated DelBS
and DbfS mutant mice carrying deletions similar to the DelB
(brachydactyly-like) and Dbf (polydactyly-like) mutants, except
that the region containing the predicted boundary element was
left intact (Figures 6B and 6C). Animals carrying these deletions
had normal limbs and did not show any other abnormalities.
Moreover, in situ hybridization for Ihh and Pax3 showed that
these genes were not misexpressed and had retained their
endogenous pattern of expression (Figures 6B and 6C, right).1020 Cell 161, 1012–1025, May 21, 2015 ª2015 Elsevier Inc.To compare the interaction profiles in the absence or presence
of boundary elements, we performed 4C-seq experiments using
Ihh or Pax3 as baits in E11.5 distal limbs. This analysis revealed
that the ectopic interactions of the corresponding gene with the
Epha4 TAD observed in DelB and Dbf mice is reduced in DelBS
andDbfSmice (Figures 6B and 6C, left). Vice versa, 4C-seq using
the enhancer cluster as bait also showed reduced interaction
with the Ihh or Pax3 promoter (Figure S7). Thus, the presence
of the boundary elements was sufficient to prevent inappropriate
cross-TAD chromatin interactions, ectopic expression of non-
target genes, and the morphological phenotypes resulting from
this misexpression.
DISCUSSION
Structural variations are common in the human genome, but
often difficult to interpret. Their inherent complexity necessitates
model systems in which the human situation can be faithfully
recapitulated and studied. Here we use an adapted CRISPR/
Cas genome editing protocol to reproduce human rearrange-
ments in mice (Kraft et al., 2015). Using this approach, we re-en-
gineered three humanmalformation-associated rearrangements
and investigated their effect on chromatin higher-order struc-
tures and gene function.
Disruption of TADs Results in Aberrant DNA Domain
Topology and Gene Misexpression
TADs are stable units of genomic architecture that have been
proposed to partition the genome into large regulatory units
(Dixon et al., 2012). To investigate the effect of structural vari-
ants on TAD integrity, we examined limbs from the different
mutant mouse strains using 4C-seq, which provides higher res-
olution than Hi-C. In all cases, we observed ectopic interaction
of Pax3,Wnt6, or Ihh with the Epha4 TAD. The extent of interac-
tion varied across the mutants, but included in all cases a min-
imal overlapping region of 150 kb (chromosome 1:75694480–
75848058, mm9). Based on the hypothesis that this region
might contain regulatory elements that drive the misexpression
of Pax3, Wnt6, and Ihh, we screened the region for enhancers
and identified a cluster of regulatory elements driving limb
expression. The pattern driven by these enhancers overlaps
with the endogenous limb expression of Epha4 and is very
similar to the misexpression domains of Pax3, Wnt6, and Ihh
observed in the mutant strains. Taken together, these data sug-
gest that the target genes near the breakpoints were adopted
by Epha4 enhancers, which in turn results in their misexpression
(Figure 7). In DelB/+ mice we did not detect any other regulated
genes. In both the InvF/InvF and the Dbf/+ mice, only one gene,
Cyp27a and Fev, respectively, showed significant upregulation
at overall marginal expression levels. Given the function of
these genes in cholesterol metabolism (Cyp27a) and the
central serotonin system (Fev), a contribution to the phenotype
seems unlikely. Ectopic expression of Wnt6 can cause limb
malformations in the chick via its anti-chondrogenic effect (Gee-
tha-Loganathan et al., 2010), and misexpression of hedgehog
proteins can induce polydactyly via the disruption of the ante-
rior-posterior GLI3 gradient (Lettice et al., 2002). While the
mechanisms by which ectopic expression of Pax3 may affect
Figure 6. Boundary Elements at Both Sides of the Epha4 TAD Prevent Ectopic Expression of Neighboring Genes
(A) CTCF ChIP-seq track in E14.5 mouse limbs (ENCODE/LICR). Red boxes and octagons mark clusters of CTCF peaks located at the boundary of the Epha4
TAD. The grey box indicates Epha4 TAD. 4C-seq profiles were generated from distal limb buds at E11.5. All data were obtained from heterozygous animals.
Aberrant interactions are indicated by red boxes. Pink scissors indicate CRISPR/Cas-induced breakpoints in each deletion.
(B) A deletion (DelBs) excluding the boundary region andCTCF cluster at the telomeric side of the Epha4 TAD (red octagon) was generated and comparedwith the
brachydactyly-like deletion (DelB, including the CTCF cluster). The log2 ratio of the 4C-seq signal ofDelB/DelBS shows increased interaction with the Epha4 TAD
in the DelB deletion when compared with DelBs deletion (red box). Pax3 (right) shows normal expression of DelBs/+ deletion mice, in contrast to Pax3 mis-
expression in DelB/+ mice (white arrow).
(C) A deletion (DbfS) excluding the boundary region and CTCF cluster at the centromeric side of the Epha4 TAD (red octagon) was generated and compared with
the doublefoot deletion (Dbf, including the CTCF cluster). The log2 ratio of the 4C-seq signal of Dbf/DbfS shows increased interaction with the Epha4 TAD in the
Dbf deletion when comparedwithDbfS deletion (red box). Ihh (right) shows an absence of limb expression inDbfs/+deletionmice, in contrast to Ihhmisexpression
in Dbf/+ deletion mice (white arrow).
See also Figure S7.skeletal morphology remain to be established, the observed
misexpression domains in combination with the morphogenetic
potential of Wnt6 and hedgehog proteins offer a plausible mo-
lecular explanation for at least two of the human phenotypes
observed.
Our 4C-seq data using the Epha4 enhancers as a viewpoint
(Figure S6) also show that the regions of ectopic interaction
cover many other genes besides the identified targets Pax3,
Ihh, and Wnt6. Nevertheless, expression analysis by RNA-seqshowed no substantial upregulation of these genes, indicating
that either enhancer-promoter distance or other unknown fac-
tors contribute to the receptiveness of a promotor to respond
to the enhancer. In a Drosophila in vitro system, housekeeping
and developmental promoters can respond to different classes
of enhancers (Zabidi et al., 2015). It is possible that similar
intrinsic specificities help to guide enhancer-promotor in verte-
brate genomes. Here, the activated genes are all developmental
genes expressed during limb development, indicating that thereCell 161, 1012–1025, May 21, 2015 ª2015 Elsevier Inc. 1021
Figure 7. A Model for Pathogenicity of Structural Variations
Wild-type conformation shows the structure of two adjacent TADs. The activity
of the enhancer (E) is restricted to gene 1 (G1) located inside the TAD. The
TADs are separated by a boundary element (black). The black boxes represent
the rearranged regions. The box with dotted lines represents the duplicated
region. In the inversion, the enhancer is moved out of TADa and placed in the
vicinity of gene 2 (G2). The boundary is now on the right side of E. This results in
interaction of E with G2, but prevents its original interaction with G1. In the
duplication, E is placed next to the duplicated G20, resulting in interaction and
misexpression. If the deletion removes the boundary and parts of TADb (black
box), E is able to interact with G1 and G2, resulting in misexpression of G2. If
the deletion leaves the boundary intact (DeletionS, black box), the TAD
structure remains intact and E interacts only with G1.may be a preference toward genes that are poised to get acti-
vated in this tissue.
Conservation of TAD Structure across Species, Tissues,
and Rearrangements
Comparison of TADs across different mouse and human cell
types suggests that their boundaries are largely conserved (Dixon
et al., 2012). We hypothesized that this conservation allows for
the analysis of disrupted regulatory interactions that occur in vivo
during early embryonic development, using patient samples
collected long after limb morphogenesis has ended. To test
this approach, we performed 4C-seq in human adult fibro-
blasts from patients with the brachydactyly-associated deletion,
the F-syndrome-associated duplication, and the polydactyly-
associated duplication (Yuksel-Apak et al., 2012). Fibroblasts
from healthy control individuals showed interaction domains
highly similar to wild-type developmental mouse limb buds,
whereas patient fibroblasts recapitulated the aberrant interac-
tions observed in the respective mutant mouse strains. The
observed chromatin interactions appear to be independent
from gene expression levels, since EPHA4 and PAX3 are ex-
pressed at robust levels, WNT6 is expressed at very low levels,1022 Cell 161, 1012–1025, May 21, 2015 ª2015 Elsevier Inc.and IHH transcript is not detectable in HAFs (data not shown).
While the ectopic interaction as well as the overall configuration
was similar between human fibroblasts and mouse limb tissue,
the distribution of peaks within the TADs was different. This
is likely due to the different transcriptional activity and differenti-
ation status of the analyzed samples (Nora et al., 2012). Regard-
less of such variation, our data indicate overall strong congru-
ence between the developing mouse tissue and human-derived
fibroblasts in the overall configuration of TADs. These results
demonstrate the potential of patient-derived chromatin interac-
tion data for gaining insight into the pathology of transient pro-
cesses that occur during embryonic development.
Perturbation of TAD Structure Results in the Formation
of New TADs
All structural variants examined in this study result in aberrant in-
teractions of a regulatory unit with ectopic-target genes that nor-
mally do not take place because enhancers interact only with
their respective target promoters. TADs have been proposed
to play an important role in establishing appropriate enhancer-
promoter interactions by providing a structural scaffold that
limits the distance and direction over which enhancers operate.
However, it remains unclear if the observed partitioning of the
genome is a cause or consequence of pervasive enhancer-pro-
moter interactions and what functional role boundary regions
between the TADs have (de Laat and Duboule, 2013). The pertur-
bation of TADs by means of chromosomal rearrangements can
provide insight into the fundamental mechanisms that drive
this process. In vitro experiments at the Xist locus, for example,
demonstrated reorganization of a TAD and spill-over of activity
upon deletion of a 58-kb element corresponding to the boundary
region (Nora et al., 2012). In the present study, variants that
delete TAD boundaries result in interaction across the domains
with no apparent new boundary formation and thus represent
an apparently seamless fusion of neighboring TADs (Figure 7).
The interactions within these apparent new TADs as well as their
exact boundaries and their impact on the overall three-dimen-
sional architecture of the locus will have to be resolved by
more quantitative analysis methods. However, the 4C-seq data
obtained in this study suggest that the new TADs are defined
by the next adjacent boundaries and that their functionality is
not impaired. In the duplications the boundaries are not removed
but the duplicated copy is flanked by an additional boundary, re-
sulting in ectopic interaction within the newly formed TAD.
Accordingly, our 4C-seq results show increased frequency of
interaction of IHH (polydactyly family) and WNT6 (F-syndrome
family) with centromeric parts of the EPHA4 domain (Figure 7,
Duplication). In the case of the inversion, the EPHA4 enhancer
cluster and the adjacent boundary is moved next to WNT6.
This results in the ectopic interaction withWNT6 and the forma-
tion of a new TAD that is now confined by the former EPHA4
centromeric boundary (Figure 7, Inversion). Similar results were
obtained at the Tfap2/Bmp2 locus, showing that inversions
can result in reorganization of TAD structure by shifting bound-
aries (Tsujimura et al., 2015). Thus, a boundary element can
be inverted or moved to a different chromosomal region
without losing its functionality. However, the minimal region to
determine boundary functionality is still unknown, and therefore
the consequences of deleting only the boundary elements re-
main to be tested.
Boundary Structures Are Important for TAD Integrity
We experimentally challenged the assumption that TAD bound-
ary elements are functional and relevant for disease pathogen-
esis by creating deletions that leave the proposed boundary
regions on either side of the Epha4 TAD intact. Both regions con-
tained a cluster of binding sites for CTCF, a factor involved in
boundary formation (Dixon et al., 2012; Van Bortle et al., 2014).
We engineered additional variants of the Dbf as well as the
brachydactyly-associated rearrangements, this time leaving
the predicted boundary regions undeleted. No phenotypes and
no misexpression of either Ihh or Pax3 were observed. Further-
more, 4C-seq experiments in these mice showed decreased fre-
quency of interaction of the target genes Pax3 and Ihh with the
Epha4 domain. Thus, leaving the proposed boundary regions
intact diminishes all molecular phenotypes and averts morpho-
logical aberrations by preventing ectopic interactions.
Distance between regulatory elements and their target genes
may be another determining factor. At the HoxD locus, for
example, duplications within the TAD that result in an increase
in the distance between promoter and enhancers were shown
to result in an impairment of activation (Montavon et al., 2012).
While we cannot rule out that distance effects contribute to the
attenuation of molecular phenotypes, the difference between
the deletion sizes is 100 kb for the Dbf/DbfS alleles and 200 kb
for the DelB/DelBS alleles, corresponding to 17% and 12% of
the total deletion size, respectively. It appears unlikely that these
minor differences in distance alone are sufficient to explain the
reversion of molecular phenotypes to near-wild-type levels,
given that similar differences in deletion size of200 kb are pre-
sent across the brachydactyly families (B1, B2, and B3) without
apparent effect on the phenotype.
A Framework for Interpreting Human Structural
Variation
Depending on their size and position, structural variants may
disrupt higher-order genomic organization. In this study we pre-
sent a conceptual framework for the interpretation of such
variants using genome-wide chromatin interaction datasets.
Our results reinforce the notion that the pathogenicity of a sub-
stantial proportion of human disease-associated deletions re-
sults from ectopic enhancer-promoter interaction causing gene
misexpression due to the elimination of annotated boundaries
(Ibn-Salem et al., 2014). The aberrant chromatin interactions
observed at the EPHA4 locus in the present study exemplify
how the disruption of TAD structure by eliminating or interfering
with boundary elements can lead to the functional rewiring of
gene-enhancer interactions (schematically shown in Figure 7).
This model also illustrates how different types of large-scale
structural changes can converge to give rise to the same pheno-
type. We showed that duplication and an inversion, as observed
in the F-syndrome cases, or duplication and a deletion, as in the
polydactyly family/mouse mutant, result in nearly identical mo-
lecular changes and morphological defects. In both cases the
target gene interacts with the same non-coding genomic region
and exhibits similar ectopic expression domains, despite thefundamentally different nature of the underlying structural muta-
tion. In the deletions, a boundary is removed from the genome,
permitting contact of the enhancer with genes outside of the
TAD. In contrast, in the inversion and the duplications the
enhancer is placed next to the new target gene. In the latter re-
arrangements the boundaries are left intact, but their new posi-
tion no longer restricts contact of the enhancer with the target
gene (Figure 7). The effect of such rearrangements is a gain of
function via misexpression of one or several target genes. On
the other hand, rearrangements of comparable size that do not
interfere with TAD boundaries can be without consequence, as
shown for theDelBS andDbfS mutants. Thus, considering overall
TAD structure and in particular the integrity of the boundaries
and their position relative to genes and enhancers appears
critical when predicting ectopic and potentially pathogenic
enhancer-promoter interactions. As this situation depends on
the presence of several factors including available enhancers
and receptive genes that can give rise to phenotypes when mis-
expressed, other pathogenicmechanisms such as loss or gain of
gene function have to be considered when interpreting structural
variations. Notably, such predictions can be experimentally
tested even if the affected tissue is not available. As shown in
this study, normal and abnormal TAD structure and enhancer-
promoter interactions may be preserved across developmental
tissues and adult human cells such as fibroblasts. Hence, 4C-
seq in patient cells can yield diagnostically valuable information
to predict effects of structural variants on gene regulation and
thus disease etiology.While the present study focused on one lo-
cus and one set of related morphological phenotypes, TAD data
for the entire human and mouse genome are becoming available
at increasing resolution (Jin et al., 2013; Rao et al., 2014). These
data should also help to interpret rearrangements in regions with
higher gene density. Thus, the general principles uncovered in
this study and the resulting approaches for the interpretation of
structural variation in human phenotypes are expected to be
applicable to other genomic loci and a wide spectrum of genetic
conditions caused by structural variants.
EXPERIMENTAL PROCEDURES
Human Material
Venous blood samples and skin biopsies and were obtained from the patients
and controls by standard procedures. Written informed consent was obtained
from all individuals studied to participate in this study. This study was
approved by the Charite´ Universita¨tsmedizin Berlin ethics committee.
Identification of Human Structural Variations
All experiments were done with genomic DNA extracted from blood. Brachy-
dactyly deletions were identified using array CGH.
F-syndrome-associated duplication and inversion were identified using next
generation sequencing (NGS, see Supplemental Information). Breakpoints for
each structural variation were identified by breakpoint spanning PCR and
Sanger sequencing.
Generation of Transgenic Animals Using CRISPR/Cas
Mouse ESCs carrying structural variations were created using a CRISPR/Cas-
based protocol (Kraft et al., 2015) (see Supplemental Information). The size and
position of the human structural variations (hg19) were converted to themouse
genome (mm9) using the USCS liftOver tool. CRISPR guides were designed
using the CRISPR design tool based on the algorithm described in Hsu et al.
(2013) to place guide sequences within close proximity of the predictedCell 161, 1012–1025, May 21, 2015 ª2015 Elsevier Inc. 1023
breakpoints (see Table S1). To minimize off target effects, guide sequences
were chosen to have a quality score above 85%.
Embryos and live animals from ESCs were generated by tetraploid comple-
mentation (Artus and Hadjantonakis, 2011). For each structural variation, at
least two independent clones were aggregated. Genotyping was performed
by PCR analysis. Guide primers, genotyping primers, and breakpoint coordi-
nates are summarized in Table S1.
RNA-Seq
E11.5 distal limbs were microdissected from wild-type or mutant embryos.
RNA was isolated from tissue samples using the RNeasy Mini Kit (QIAGEN).
Samples were sequenced using Illumina HiSeq technology according to stan-
dard protocols.
In Vivo Enhancer Validation
Putative enhancer regions were selected on the basis of public tracks for
H3K27Ac ChIP-seq (Cotney et al., 2012), DNase HS, p300 ChIP-seq data
from 11.5 limbs (Visel et al., 2009b), and conservation available at the USCS
genome browser (http://genome.ucsc.edu/). Selected regions were amplified
by PCR from mouse genomic DNA and cloned into a Hsp68-promoter-LacZ
reporter vector as previously described (Visel et al., 2009b) (see Table S2).
Transgenic embryos were generated and tested for LacZ reporter activity at
E11.5. All animal work performed at Lawrence Berkeley National Laboratory
was reviewed and approved by the institutional Animal Welfare and Research
Committee (AWRC).
In Situ Hybridization and Skeletal Preparations
In situ hybridization was performed according to standard protocols. Probes
from Pax3, Ihh, Wnt6, and Epha4 were generated by PCR amplification using
mouse limb cDNA. For skeletal preparation, specimens were stained accord-
ing to standard Alcian blue/Alizarin red protocols.
All animal procedures were in accordance with institutional, state, and gov-
ernment regulations (Berlin: LAGeSo).
4C-Seq
4C-seq libraries were generated from microdissected tissues or cells as
described previously (van deWerken et al., 2012). BglII or HindIII (6-bp cutters)
were used as primary restriction enzymes. Csp6I or DpnII were used as
secondary restriction enzymes. For each viewpoint, a total of 1.6 mg of
each library was amplified by PCR (primer sequence in Table S3). Samples
were sequenced with Ilumina Hi-Seq technology according to standard
protocols.
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seven figures, and three tables and can be found with this article online at
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